Displaying all 2 publications

Abstract:
Sort:
  1. Fulltext Exploring Radiographers' Readiness for Artificial Intelligence in Kuwait: Insights and Applications
    Khalaf A, Alshammari M, Zayed H, Emnawer M, Esfahani A
    Health Sci Rep, 2025 Apr;8(4):e70465.
    PMID: 40161002 DOI: 10.1002/hsr2.70465
    INTRODUCTION: There is a growing adoption of artificial intelligence (AI) in the field of medical imaging. AI can potentially enhance patient care, improve workflow, and analyze patient's medical data. This study aimed to explore radiographers' knowledge, perceptions, and expectations toward integrating AI into medical imaging and to highlight one of the available applications of AI by evaluating an AI-based software that generates chest reports.

    METHODS: A cross-sectional survey was distributed to radiographers (n = 50) requesting information regarding demographics and knowledge of AI. In the retrospective part, chest radiographs were collected (n = 40), and an AI report was generated using Siemens AI software. A Likert scale was used by a radiologist to rate the report's accuracy. Ethical approval was obtained. Data are presented as mean ± SD.

    RESULTS: The survey results showed that most participants agreed that radiographers must adapt the AI technology, and they showed interest in taking courses about AI within radiography (98%, 92%, n = 50). Participants' opinions on AI correlated with their perceptions of AI education (p 

  2. Fulltext An updated overview of cyanidins for chemoprevention and cancer therapy
    Posadino AM, Giordo R, Ramli I, Zayed H, Nasrallah GK, Wehbe Z, et al.
    Biomed Pharmacother, 2023 Jul;163:114783.
    PMID: 37121149 DOI: 10.1016/j.biopha.2023.114783
    Anthocyanins are colored polyphenolic compounds that belong to the flavonoids family and are largely present in many vegetables and fruits. They have been used in traditional medicine in many cultures for a long time. The most common and abundant anthocyanins are those presenting an O-glycosylation at C-3 (C ring) of the flavonoid skeleton to form -O-β-glucoside derivatives. The present comprehensive review summarized recent data on the anticancer properties of cyanidings along with natural sources, phytochemical data, traditional medical applications, molecular mechanisms and recent nanostrategies to increase the bioavailability and anticancer effects of cyanidins. For this analysis, in vitro, in vivo and clinical studies published up to the year 2022 were sourced from scientific databases and search engines such as PubMed/Medline, Google scholar, Web of Science, Scopus, Wiley and TRIP database. Cyanidins' antitumor properties are exerted during different stages of carcinogenesis and are based on a wide variety of biological activities. The data gathered and discussed in this review allows for affirming that cyanidins have relevant anticancer activity in vitro, in vivo and clinical studies. Future research should focus on studies that bring new data on improving the bioavailability of anthocyanins and on conducting detailed translational pharmacological studies to accurately establish the effective anticancer dose in humans as well as the correct route of administration.
Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links